255 related articles for article (PubMed ID: 27981485)
1.
Montemezzi S; Cavedon C; Camera L; Meliadò G; Caumo F; Baglio I; Sardanelli F
Radiol Med; 2017 Mar; 122(3):161-170. PubMed ID: 27981485
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of total choline (tCho) quantification in suspicious lesions on multiparametric breast MRI.
Sodano C; Clauser P; Dietzel M; Kapetas P; Pinker K; Helbich TH; Gussew A; Baltzer PA
Eur Radiol; 2020 Jun; 30(6):3371-3382. PubMed ID: 32065286
[TBL] [Abstract][Full Text] [Related]
3. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
Suppiah S; Rahmat K; Mohd-Shah MN; Azlan CA; Tan LK; Aziz YF; Vijayananthan A; Wui AL; Yip CH
Clin Radiol; 2013 Sep; 68(9):e502-10. PubMed ID: 23706826
[TBL] [Abstract][Full Text] [Related]
4. Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.
Vassiou K; Tsougos I; Kousi E; Vlychou M; Athanasiou E; Theodorou K; Arvanitis DL; Fezoulidis IV
Acta Radiol; 2013 May; 54(4):380-8. PubMed ID: 23436823
[TBL] [Abstract][Full Text] [Related]
5. High-field MR spectroscopy in the multiparametric MRI evaluation of breast lesions.
Cavedon C; Meliadò G; Rossi L; Camera L; Baglio I; Caumo F; Montemezzi S
Phys Med; 2016 Dec; 32(12):1707-1711. PubMed ID: 27637861
[TBL] [Abstract][Full Text] [Related]
6. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy.
Cecil KM; Schnall MD; Siegelman ES; Lenkinski RE
Breast Cancer Res Treat; 2001 Jul; 68(1):45-54. PubMed ID: 11678308
[TBL] [Abstract][Full Text] [Related]
7. 1H-MRS evaluation of breast lesions by using total choline signal-to-noise ratio as an indicator of malignancy: a meta-analysis.
Wang X; Wang XJ; Song HS; Chen LH
Med Oncol; 2015 May; 32(5):160. PubMed ID: 25895597
[TBL] [Abstract][Full Text] [Related]
8. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study.
Bartella L; Morris EA; Dershaw DD; Liberman L; Thakur SB; Moskowitz C; Guido J; Huang W
Radiology; 2006 Jun; 239(3):686-92. PubMed ID: 16603660
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases.
Yeung DK; Yang WT; Tse GM
Radiology; 2002 Oct; 225(1):190-7. PubMed ID: 12355004
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
[TBL] [Abstract][Full Text] [Related]
11. 1H MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy?
Tozaki M; Fukuma E
AJR Am J Roentgenol; 2009 Sep; 193(3):840-9. PubMed ID: 19696300
[TBL] [Abstract][Full Text] [Related]
12. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy.
Mackinnon WB; Barry PA; Malycha PL; Gillett DJ; Russell P; Lean CL; Doran ST; Barraclough BH; Bilous M; Mountford CE
Radiology; 1997 Sep; 204(3):661-6. PubMed ID: 9280241
[TBL] [Abstract][Full Text] [Related]
13. Comparative Investigation of Single Voxel Magnetic Resonance Spectroscopy and Dynamic Contrast Enhancement MR Imaging in Differentiation of Benign and Malignant Breast Lesions in a Sample of Iranian Women.
Faeghi F; Baniasadipour B; Jalalshokouhi J
Asian Pac J Cancer Prev; 2015; 16(18):8335-8. PubMed ID: 26745081
[TBL] [Abstract][Full Text] [Related]
14. In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy.
Sardanelli F; Fausto A; Di Leo G; de Nijs R; Vorbuchner M; Podo F
AJR Am J Roentgenol; 2009 Jun; 192(6):1608-17. PubMed ID: 19457825
[TBL] [Abstract][Full Text] [Related]
15. Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy.
Bartella L; Thakur SB; Morris EA; Dershaw DD; Huang W; Chough E; Cruz MC; Liberman L
Radiology; 2007 Oct; 245(1):80-7. PubMed ID: 17885182
[TBL] [Abstract][Full Text] [Related]
16. Single voxel in vivo proton magnetic resonance spectroscopy of breast lesions: experience in 77 cases.
Başara I; Örgüç Ş; Coşkun T
Diagn Interv Radiol; 2013; 19(3):221-6. PubMed ID: 23271501
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of MR spectroscopy for characterizing malignant breast lesions using a clinical 3-T scanner.
Baek HM; Lee YJ
Breast Cancer; 2015 Sep; 22(5):510-9. PubMed ID: 24390858
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance spectroscopy of the breast at 3T: pre- and post-contrast evaluation for breast lesion characterization.
Kousi E; Tsougos I; Vasiou K; Theodorou K; Poultsidi A; Fezoulidis I; Kappas C
ScientificWorldJournal; 2012; 2012():754380. PubMed ID: 22645448
[TBL] [Abstract][Full Text] [Related]
19. Role of second-look ultrasound examinations for MR-detected lesions in patients with breast cancer.
Lee SH; Kim SM; Jang M; Yun BL; Kang E; Kim SW; Park SY; Ahn HS; Chang JH; Yoo Y; Song TK; Moon WK
Ultraschall Med; 2015 Apr; 36(2):140-8. PubMed ID: 25750138
[TBL] [Abstract][Full Text] [Related]
20. Fast 3D Near-infrared breast imaging using indocyanine green for detection and characterization of breast lesions.
Schneider P; Piper S; Schmitz CH; Schreiter NF; Volkwein N; Lüdemann L; Malzahn U; Poellinger A
Rofo; 2011 Oct; 183(10):956-63. PubMed ID: 21972043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
